The International Vaccine Institute (IVI), the first international organization with headquarters in the Republic of Korea, will hold its annual meetings of the Board of Trustees (BOT) and the Institute Support Council at the Hoam Faculty House on the campus of Seoul National University from April 10 to 12.
A new country -- the Republic of Cote D'Ivoire (Ivory Coast) - will be officially ratified as an IVI Signatory during the meeting. This will increase the number of IVI Signatories to 38, including the World Health Organization (WHO).
The Board will elect two new members to replace Professor Jan Holmgren of Gothenburg University in Sweden, and Emeritus Professor Ian Gust of the University of Melbourne in Australia, who are completing their second three-year term. The Board will also approve IVI's work plan and budget for the coming fiscal year. Key outcomes from the meeting will be announced on Wednesday, April 12.
Established in 1997 as an initiative of the United Nations Development Program (UNDP), the IVI is an independent international organization under the Vienna Convention, which is governed by the 21-member board. Board members include two ex-officio seats each named by the Korean government and WHO, as well as one by UNDP. The board also has five seats for representatives of Signatory countries, while the remaining members are leading vaccinologists from around the world, serving in their individual capacities.
The Institute Support Council (ISC), comprising representatives of Signatories and other supporters of the IVI, will meet on Wednesday in conjunction with the BOT. The ISC, chaired by Prof. Nay Htun at United Nations University of Peace, seeks to enhance the IVI's global visibility and partnerships, and to mobilize additional funding for its research, while advising the Board and the Institute on priorities and policies. Key ISC Executive Committee members include Mr. Jeffery Jones, former Chairman of the American Chamber of Commerce in Korea, and Ms. Joanne Lee, President of Star Communication.
Earlier on April 8 and 9, the IVI will convene the Scientific Advisory Group (SAG) meeting, a panel of around ten leading experts in vaccinology and related fields, who help guide the Institute's science programs, at its headquarters on the campus of SNU.
The IVI is the world's only international organization devoted exclusively to research and development of new vaccines for the world's poorest children. It is supported by the governments of several countries, philanthropists including the Bill and Melinda Gates Foundation, and corporate and individual donors.